HI homepage

Trending
Fewer than 30% of FDA-cleared AI devices share key safety, adverse event info prior to approval
Does BMI affect AI's accuracy when assessing CT scans?
New GE HealthCare partnership expands access to prostate cancer imaging agent
Repetitive head impact in soccer players increases risk of brain damage, MRI shows
Expert panel develops new breast biopsy guidelines
Howard Berger, MD, RadNet chairman and CEO, discusses why the company has invested millions into DeepHealth to rapidly build up a new business model for artificial intelligence capabilities in radiology. #RSNA #HealthAI #ClinicalAI #Radiology
Why RadNet is betting heavily on AI to reshape radiology workflows

RadNet Chaiman and CEO Howard Berger, MD, explains why the company has invested tens of millions into DeepHealth to rapidly build up a new business model. 

 

Congress Senate Washington D.C. DC
Republicans win shutdown showdown—Senate agrees to funding deal without ACA subsidy extension

With eight Democrats agreeing to the Republican-backed deal that reverses the firings of federal workers, the Senate now has the 60 votes needed for the bill to advance. The rehirings will include the 1,200 workers fired at the Department of Health and Human Services. 

lung cancer screening
Study highlights CT findings that could mask lung cancer, leading to delayed diagnosis

For many patients with interstitial lung disease, cancer could go undetected for years, putting them at risk of disease progression that would require more extensive treatment.

Video interview with Allen Taylor, MD, chairman of cardiology at Medstar, who explains use of AI CCTA plaque analysis at Medstar to improve risk assessments.
AI software takes cardiac risk assessments to another level

Allen Taylor, MD, thinks AI-powered plaque evaluations can make a substantial impact on patient care. 

Interview with Alan Matsumoto, chair of American College of Radiology (ACR) Board, says Medicare physician payments are not sustainable, forcing many practices to consolidate with health systems or private equity owned companies.
ACR board chair discusses radiology's 'culture clash' between 'suits and white coats'

Alan Matsumoto, MD, explains the pros and cons of consolidation under hospital system and private equity ownership.

Bacteria-based contrast agent lights up tumor margins significantly better than other agents.
Bacteria-based contrast agent offers 'substantial improvements' for tumor border delineation during surgery

Essentially, the agent places a bright neon sign on the entirety of tumors and their borders, and it does so autonomously. 
PET/MR findings in long COVID patients linked to long-term cardiopulmonary diseases

Experts suggest abnormal findings on cardiopulmonary PET/MR should be considered a risk factor for long-term complications in COVID patients. 
CT workflows improve with help of deep learning 3D camera for patient positioning

These specialized, AI-powered cameras can automate and optimize patient positioning based on their body habitus and placement on the table.

MRI safety magnet on warnings 1.5T Philiups Mobile BlueSeal system RSNA23 DF
Update: New details emerge about fatal MRI accident in Long Island

The man's wife says he was accompanying her for an MRI of her knee when the tragedy occurred.

Around the web

Radiology Business
Why RadNet is betting heavily on AI to reshape radiology workflows

RadNet Chaiman and CEO Howard Berger, MD, explains why the company has invested tens of millions into DeepHealth to rapidly build up a new business model. 

 

Cardiovascular Business
AI turns mammograms into CVD risk assessments—no outside data required

Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.

Radiology Business
Fewer than 30% of FDA-cleared AI devices share key safety, adverse event info prior to approval

A new analysis is prompting questions regarding how rigorously many of the AI-enabled tools approved by the U.S. Food and Drug Administration are evaluated prior to their clearance.